← All Sponsors
SPONSOR

Biohaven Therapeutics Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 2, Phase 3
Conditions studied: Focal Epilepsy
NCT06309966 Phase 2, Phase 3
Recruiting

Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Focal Epilepsy
United States, Australia, Denmark View Trial →